Eastman Chemical (EMN)
(Delayed Data from NYSE)
$109.27 USD
+0.27 (0.25%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $109.30 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$109.27 USD
+0.27 (0.25%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $109.30 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Zacks News
Eastman Chemical (EMN) Set to Increase Prices of Esters
by Zacks Equity Research
Eastman Chemical (EMN) increases off-list prices of Esters in North and Latin America.
Eastman Chemical (EMN) Announces Start of MDIPA Unit in China
by Zacks Equity Research
Eastman Chemical's (EMN) move reflects commitment to customers as well as ability to execute projects safely and timely. It is expanding its alkyl alkanolamine capacity in Nanjing.
Near-Term Prospects Cloudy for Diversified Chemical Stocks
by Zacks Equity Research
Diversified chemical companies are hamstrung by raw material cost pressure and ongoing trade tensions between Washington and Beijing.
Eastman Chemical (EMN) Q3 Earnings, Revenues Top Estimates
by Anindya Barman
Eastman Chemical's (EMN) Q3 results surpassed expectations and the company reaffirmed its earnings growth outlook for 2018.
Eastman Chemical (EMN) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 2.18% and 0.48%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Earnings Slated for Oct 25: PX, EMN & AXTA
by Zacks Equity Research
Investors should check these chemical stocks before their quarterly results as the industry is expected to sustain the momentum in Q3.
Can Eastman Chemical (EMN) Sustain Earnings Streak in Q3?
by Anindya Barman
Eastman Chemical's (EMN) high margin products and productivity actions are likely to support its Q3 earnings.
LyondellBasell's PP Copolymer Advances Medicine Storage
by Zacks Equity Research
LyondellBasell's (LYB) Purell EP374M product maintains toughness and impact resistance within a broad temperature window.
Eastman Chemical (EMN) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Eastman Chemical (EMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese to Raise Prices of Ateva EVA & VAE Emulsion Polymers
by Zacks Equity Research
Celanese (CE) takes appropriate pricing actions amid a volatile pricing environment for raw materials.
5 Reasons to Add Eastman Chemical (EMN) to Your Portfolio
by Anindya Barman
Based on its compelling prospects, we believe Eastman Chemical (EMN) has plenty of upside potential.
Eastman Chemical Hikes DMAPA Prices Amid High Operating Costs
by Zacks Equity Research
Eastman Chemical's (EMN) latest pricing action is in response to elevated operation costs, especially of raw materials.
Eastman Chemical (EMN) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Celanese (CE) Poised to Gain on Productivity & Growth Actions
by Anindya Barman
Celanese's (CE) productivity actions and growth initiatives, including acquisitions, are likely to lend support to its earnings in 2018.
Eastman Chemical to be Aided by Acquisitions & Cost Reduction
by Zacks Equity Research
Eastman Chemical's (EMN) strategic acquisitions and cost-cutting actions are likely to drive growth, amid headwinds from raw-material cost inflation.
Eastman Chemical Raises Prices of Methanol Methyl Acetate
by Zacks Equity Research
Eastman Chemical (EMN) plans to lift list and off-list prices of Methyl Acetate in North America starting Oct 1.
Eastman Chemical Set to Raise Copolyesters Products Prices
by Zacks Equity Research
Eastman Chemical's (EMN) Specialty Plastic Business is implementing price increases for Copolyesters products owing to increased operating costs, especially of raw materials.
Eastman Chemical (EMN) Set to Hike Prices of Plasticizers
by Zacks Equity Research
Eastman Chemical (EMN) raises prices of plasticizers owing to increased operating costs, especially of raw materials.
Eastman Chemical (EMN) Expands PVB Production Capabilities
by Zacks Equity Research
The expansion is specifically focused on enhancing production capacity of Eastman Chemical's (EMN) advanced acoustic interlayer products.
Eastman Chemical Gets C2C Certification for Polymer Products
by Zacks Equity Research
Eastman Chemical (EMN) for the first time has been awarded the Platinum-level Material Health Certificate.
Eastman Chemical (EMN) Hikes Prices of Glycol Products
by Zacks Equity Research
Eastman Chemical (EMN) raises off-list prices of Glycol products in North and Latin America.
Eastman Chemical (EMN) Raises Prices of Plasticizers
by Zacks Equity Research
Eastman Chemical (EMN) increases Plasticizers prices due to elevated costs of raw materials.
Eastman Chemical (EMN) Raises Prices of Acids and Alcohols
by Zacks Equity Research
Eastman Chemical (EMN) hikes acid and alcohol product prices due to higher market demand and elevated operating costs of raw materials.
Eastman Chemical (EMN) Raises Off-list Prices of Benzoic Acid
by Zacks Equity Research
Eastman Chemical's (EMN) latest pricing action is in response to elevated operating expenses.
Eastman Chemical (EMN) Raises Prices of Glycol Products
by Zacks Equity Research
Eastman Chemical (EMN) raises off-list prices of products in North America.